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Abstract
Inhibitors of endosome acidification or cathepsin proteases attenuated infections mediated by envelope proteins of
xenotropic murine leukemia virus-related virus (XMRV) and Ebola virus, as well as ecotropic, amphotropic, polytropic, and
xenotropic murine leukemia viruses (MLVs), indicating that infections by these viruses occur through acidic endosomes and
require cathepsin proteases in the susceptible cells such as TE671 cells. However, as previously shown, the endosome
acidification inhibitors did not inhibit these viral infections in XC cells. It is generally accepted that the ecotropic MLV
infection in XC cells occurs at the plasma membrane. Because cathepsin proteases are activated by low pH in acidic
endosomes, the acidification inhibitors may inhibit the viral infections by suppressing cathepsin protease activation. The
acidification inhibitors attenuated the activities of cathepsin proteases B and L in TE671 cells, but not in XC cells. Processing
of cathepsin protease L was suppressed by the acidification inhibitor in NIH3T3 cells, but again not in XC cells. These results
indicate that cathepsin proteases are activated without endosome acidification in XC cells. Treatment with an endocytosis
inhibitor or knockdown of dynamin 2 expression by siRNAs suppressed MLV infections in all examined cells including XC
cells. Furthermore, endosomal cathepsin proteases were required for these viral infections in XC cells as other susceptible
cells. These results suggest that infections of XC cells by the MLVs and Ebola virus occur through endosomes and pH-
independent cathepsin activation induces pH-independent infection in XC cells.
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Introduction
Murine leukemia viruses (MLVs) are divided into four groups
according to their host ranges. Ecotropic MLV (Eco-MLV) infects
mouse and rat cells. Amphotropic MLV (Ampho-MLV) infects
many types of mammals including mouse, rat, mink, and human.
The Eco- and Ampho-MLVs recognize cationic amino acid
transporter 1 (CAT1) [1] and phosphate symporter 2 (Pit2) [2,3,4]
as the infection receptors, respectively. Polytropic (Poly-) and
xenotropic (Xeno-) MLVs both utilize the cell surface receptor
protein XPR as the infection receptor [5,6,7]. The Poly- and
Xeno-MLVs infect many types of mammals; however, the latter
does not infect laboratory mice.
The MLV entry into the host cell cytoplasm occurs through
membrane fusion between the viral envelope and host cell
membranes. This membrane fusion is induced by viral envelope
(Env) glycoproteins. The MLV Env protein has 16-amino acids at
its C-terminal tail that is cleaved during virion maturation. The C-
terminal proteolytic fragment is referred to as the R peptide. The
R peptide-truncated Eco-MLV Env protein induces membrane
fusion, while the full-length Env protein lacks this activity,
indicating that the R peptide inhibits membrane fusion [8,9,10].
This membrane fusion activity enables proteolytically cleaved
Env-expressing cells to fuse with neighboring susceptible cells,
which may reflect the viral entry process.
Endosomal acidification also plays a role in the MLV infectious
cycle. The Eco- and Ampho-MLV infections are suppressed by
endosome acidification inhibitors that induce a rise in the pH of
endosomes, showing that these viral infections require endosome
acidification and occur through acidic endosomes [11,12].
However, it has not been elucidated to date whether infections
by the Poly- and Xeno-MLVs occur through acidic endosomes. A
potential mechanism explaining the requirement for endosome
acidification has recently been reported. Endosomal cathepsin
proteases B and L are involved in the Eco-MLV infection [13,14],
and the cathepsin proteases are activated by low pH in acidic
endosomes. Therefore, endosome acidification inhibitors may
suppress the Eco-MLV infection by attenuating cathepsin protease
activation. It is unknown whether cathepsins B and L play a role(s)
in the Ampho-, Poly- and Xeno-MLV infections.
XC cells were established from a rat muscle tumor induced by
Rous sarcoma virus [15], and are widely used to titrate Eco-
MLVs, as the number of plaques resulting from the Eco-MLV-
induced cell-cell fusion correlates with the viral titer [16]. It is
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distinct from other susceptible cells. pH-independent cell-cell
fusion is induced in XC cells by the Eco-MLV infection [16], or by
the R peptide-containing Eco-MLV Env protein [17,18], but not
in other susceptible cells. In addition, ammonium chloride, which
increases the pH of endosomes, inhibits the Eco-MLV infection in
many susceptible cells, but not in XC cells, indicating that the Eco-
MLV infection in XC cells is independent of low pH in endosomes
[11]. Therefore, it is generally accepted that the Eco-MLV enters
XC cell at the plasma membrane, and enters other susceptible cells
through acidic endosomes [11,19].
In this study, we investigated whether the Poly-, Xeno-, and
XMRV-MLV vector infections occur through acidic endosomes
and whether these infections require cathepsin protease activity.
We also examined the pH-independent mechanism of MLV
infections in XC cells. We found that the Poly- Xeno-, and
XMRV-MLV vector infections occur through acidic endosomes
and require cathepsin proteases similar to the Eco-MLV, Ampho-
MLV, and Ebola virus infections. The endosome acidification
inhibitors attenuated all these viral infections in NIH3T3 and
TE671 cells, but had no effect in XC cells, as previously shown
[11]. The endosome acidification inhibitors attenuated cathepsin
protease activities in TE671 cells, but had no effect in XC cells,
indicating that cathepsin proteases are activated without
endosome acidification in XC cells. Suppression of endocytosis
by a dynamin GTPase inhibitor, dynasore, or by siRNA-
mediated knockdown of dynamin 2 expression attenuated the
MLV infections in all cells examined (including XC cells),
showing that these infections occur through endosomes even in
XC cells. These results show that cathepsin proteases are
activated in the absence of endosome acidification in XC cells
and that pH-independent virus infections occur through endo-
somes in these cells.
Results
Eco-MLV infection of XC cells is independent of
endosomal acidification
Ammonium chloride, which acts as a weak base and inhibits the
acidification of endosomes, attenuates the Eco-MLV infection in
NIH3T3 cells but not in XC cells [11]. This result suggests that the
Eco-MLV entry into XC cells occurs at the plasma membrane and
does not depend on endosome acidification. To test whether
endosome acidification is required for the Eco-MLV infection in
XC cells, we monitored the effects of concanamycin A (ConA) and
bafilomycin A-1 (BFLA-1) on this process. MLV vectors carrying
LacZ gene as a marker were pseudotyped with various viral
envelope glycoproteins as described in Materials and Methods.
Mouse NIH3T3, rat XC, and human TE671 cells expressing the
Eco-MLV receptor (TE671/mCAT1) [14] were pretreated with
the inhibitors for 5 h, and were inoculated with the Eco- or VSV-
pseudotyped MLV vector diluted with fresh medium in absence of
the inhibitor to minimize the effects on other steps of the MLV
vector infection than entry (such as uncoating and reverse
transcription). Treatment of NIH3T3 and TE671/mCAT1 cells
with the inhibitors attenuated the Eco- and VSV-MLV vector
infections (Fig. 1A). The treatment of XC cells inhibited the VSV-
MLV vector infection, indicating that the treatment with ConA or
BFLA-1 inhibited endosome acidification in XC cells. However,
the treatment of XC cells did not attenuate the Eco-MLV vector
infection as reported [11]. These results show that the Eco-MLV
infection in XC cells does not require endosome acidification,
while NIH3T3 and TE671/mCAT1 cells require endosome
acidification for the infection.
XC cells are a rat cell line. We analyzed the effect of ConA
treatment on the Eco-MLV infection in other rat cell lines (F10
and L6) as well as a mouse cell line (SC-1). The ConA treatment of
all these cell lines efficiently inhibited the Eco-MLV vector
infection (Fig. 1B), indicating that XC cells are unique cells in
which the Eco-MLV infection is pH-independent.
We have already analyzed the effects of a cathepsin protease
inhibitor, CA-074Me, on the Eco-MLV infection in NIH3T3,
XC, and TE671/mCAT1 cells, and reported that the treatment
efficiently and similarly suppresses the Eco-MLV vector infection,
but moderately attenuated the VSV-MLV vector infection [14].
These results indicate that the Eco-MLV infection in XC cells does
not require endosome acidification, but does cathepsin proteases.
Conditioned media induce pH-independent infection in
NIH3T3 cells
It has been postulated that secreted cathepsins are involved with
the pH-independent Eco-MLV infection in XC cells [13]. To
assess the hypothesis, we analyzed the effects of conditioned media
of XC, NIH3T3, NP2, and TE671 cells on the pH-dependent
MLV infection in NIH3T3 cells. Optimal condition of cathepsin B
and L activities is acidic. Culture supernatants of XC and TE671
cells were both yellow, suggesting that pH values of the
supernatants are low. However, during dilution of the MLV
vector with the conditioned media, the diluted MLV vector
solution rapidly became red. pH values of the MLV vectors diluted
with the conditioned media were 6.5 to 7.0, when the vectors were
inoculated to target cells.
Dilution of the Eco-MLV vector with the conditioned media of
XC, NIH3T3, TE671, and NP2 cells attenuated the infection by
about 1/10 (data not shown). When the MLV vector was diluted
with the XC cell conditioned medium, the inhibitory effect of
ConA on the Eco-MLV infection in NIH3T3 cells was diminished
(Fig. 2A). The conditioned media of TE671 and NIH3T3 cells, in
which the Eco-MLV infection is pH-dependent (Fig. 1A), also
induced pH-independent infection in NIH3T3 cells. However, the
TE671 cell conditioned medium did not abrogate the inhibitory
effect of ConA on the VSV-MLV vector infection. XC and TE671
cells indeed secreted cathepsins B and L (Fig. 2B). When cathepsin
B activity of the conditioned media was measured at pH 7.0,
fluorescence intensities of the XC and TE671 cell conditioned
media were reduced to about 1/3 time compared with those at
pH 5.0, but were still higher than that of fresh medium. Cathepsin
L activity of these conditioned media at pH 7.0 was moderately
lower than that at pH 5.0, and was higher than that of fresh
medium. These results indicate that cathepsins B and L are active
at pH 7.0 in the conditioned media, and suggest that secreted
cathepsins in the conditioned media induce the pH-independent
Eco-MLV vector infection in NIH3T3 cells.
However, even when the Eco-MLV vector was diluted with
fresh medium, ConA did not attenuate the Eco-MLV infection in
XC cells (Figs. 1A and 2A). Furthermore, the conditioned media of
NIH3T3, NP2, and TE671 cells, in which the Eco-MLV infection
is pH-dependent, also induced the pH-independent Eco-MLV
infection (Fig. 2A). Additionally, cathepsin B activity of the TE671
cell conditioned medium was higher than those of the XC cell
conditioned medium (Fig. 2B). If secreted cathepsin proteases are
determinant for the XC cell-specific, pH-independent Eco-MLV
infection, the endosome acidification inhibitors would not suppress
the Eco-MLV infection in TE671 cells. However, the inhibitors
significantly attenuated the Eco-MLV infection in TE671 cells
(Figs. 1A and 2A). These results indicate that secreted cathepsins
are not involved in the XC cell-specific, pH-independent Eco-
MLV infection.
pH-Independent Infection by MLV in XC Cells
PLoS ONE | www.plosone.org 2 October 2011 | Volume 6 | Issue 10 | e26180Secreted cathepsin proteases induce pH-independent
Eco-MLV infection in NIH3T3 cells
The above results suggested that conditioned media induce the
pH-independent Eco-MLV infection by secreted cathepsin
proteases. To assess this assumption, we analyzed the effects of
purified cathepsin B (100 ng/ml) on the pH-dependent Eco-MLV
infection in NIH3T3 cells. It has been reported that addition of
cathepsin B at similar concentration enhances the Eco-MLV
infection in cathepsin B-negative cells [13]. Although addition of
cathepsin B reduced the Eco-MLV vector infection by about 1/5
(data not shown), it diminished the inhibitory effect of ConA on
the Eco-MLV vector infection in NIH3T3 cells (P,0.05) (Fig. 3A).
This result shows that addition of cathepsin B induces the pH-
independent Eco-MLV infection in NIH3T3 cells.
To address whether the conditioned medium abrogates the
inhibitory effect of ConA on the Eco-MLV infection by secreted
cathepsins, we analyzed the effects of cathepsin inhibitor III
suppressing both cathepsins B and L on the conditioned medium-
induced pH-independent Eco-MLV infection in NIH3T3 cells.
ConA-pretreated NIH3T3 cells were inoculated with the Eco-
MLV vector diluted with the TE671 cell conditioned medium in
presence of cathepsin inhibitor III. Cathepsin inhibitor III at
200 mM significantly suppressed the induction of pH-independent
infection by the conditioned medium (Fig. 3B). Because cathepsin
inhibitor III is not membrane permeable, the treatment of target
cells at 200 mM did not attenuate infection of NIH3T3 cells by the
Eco-MLV vector diluted with fresh medium (Fig. 3C). Cathepsin
inhibitor III indeed attenuated activities of cathepsin proteases B
and L in the TE671 cell conditioned medium (Fig. 3D). We have
previously reported that a membrane unpermeable cathepsin L
inhibitor, CLIK148, attenuates the Eco-MLV infection at
1000 mM [14], suggesting that much higher concentration of the
unpermeable cathepsin inhibitor III is required for inhibition of
the Eco-MLV vector infection than the permeable cathepsin
inhibitor CA-074Me. These results indicate that secreted cathep-
sin proteases present in the conditioned media induce the pH-
independent Eco-MLV infection in NIH3T3 cells.
Secreted cathepsins are not involved in the XC cell-
specific, pH-independent Eco-MLV infection
Even when the Eco-MLV vector was diluted with fresh
medium, the Eco-MLV vector infection was pH-independent in
XC cells. To assess whether cathepsins secreted from XC cells are
involved in the XC cell-specific, pH-independent Eco-MLV
infection, we analyzed the effect of cathepsin inhibitor III on the
infection of XC cells by the Eco-MLV vector diluted with fresh
medium. XC cells were inoculated with the diluted Eco-MLV
vector, in the presence of cathepsin inhibitor III (200 mM).
However, cathepsin inhibitor III did not affect the infection of XC
cells by the Eco-MLV vector diluted in fresh medium (Fig. 3C).
When we proposed that secreted cathepsins induce the pH-
independent Eco-MLV infection in XC cells, we thought that the
Eco-MLV infection would occur at the plasma membrane in XC
cells. However, since cathepsin inhibitor III attenuated the
cathepsin activity in the TE671 cell conditioned medium
(Fig. 3D), but did not affect the Eco-MLV infection in XC cells,
the Eco-MLV infection in the treated XC cells probably occurs
through a different pathway than cell surface entry. It is most likely
Figure 1. Eco-MLV infection in XC cells is independent of endosome acidification. (A) Relative titers of the Eco- or VSV-MLV vector on
ConA- or BFLA-1-treated NIH3T3, TE671/mCAT1, and XC cells were indicated. (B) Relative titers of the Eco-MLV vector on ConA-treated mouse SC-1,
rat F10, and L6 cells were indicated. The transduction units obtained with DMSO-treated cells were set to 100%. These experiments were repeated in
triplicate, and results are shown as the mean +/2 SD. Asterisks indicate statistically significant differences compared to the value from the DMSO-
treated cells.
doi:10.1371/journal.pone.0026180.g001
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PLoS ONE | www.plosone.org 3 October 2011 | Volume 6 | Issue 10 | e26180Figure 2. Conditioned media induce pH-independent Eco-MLV infection. (A) NIH3T3 cells were pretreated with ConA, and were inoculated
with the Eco-MLV vector diluted with fresh or conditioned media. The transduction units obtained with DMSO-treated cells were set to 100%. These
experiments were repeated in triplicate, and results are shown as the mean +/2 SD. Asterisks indicate statistically significant differences compared to
the value from the DMSO-treated cells. (B) Cathepsin B (left panel) and L (right panel) activities of TE671 and XC cell conditioned media were
measured at pH 5.0 or 7.0. Fluorescence intensities were indicated. This experiment was repeated three times, and results are shown as means +/2
SD.
doi:10.1371/journal.pone.0026180.g002
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treated XC cells occurs through acidic endosomes, since
cathepsins are required for the Eco-MLV infection in XC cells
[14], and because active cathepsin proteases are primarily
localized to acidic endosomes. Since CA-074Me significantly
inhibited the Eco-MLV vector infection in XC cells [14], the Eco-
MLV infection does not occur through a cathepsin-independent
pathway(s). Therefore, cathepsin inhibitor III should confer the
Eco-MLV infection pathway from the cell surface to the acidic
endosomes, and thus no change in the Eco-MLV vector titers
Figure 3. Secreted cathepsin proteases induce pH-independent Eco-MLV infection. (A) NIH3T3 cells were pretreated with ConA, and were
inoculated with Eco-MLV vector diluted with fresh medium containing purified cathepsin B (100 ng/ml). (B) NIH3T3 cells were pretreated with ConA,
and were inoculated with the Eco-MLV vector diluted with fresh or TE671 cell conditioned medium in the presence of cathepsin inhibitor III (200 mM).
(C) NIH3T3 and XC cells were pretreated with ConA (3 nM) or cathepsin inhibitor III (200 mM). The treated cells were inoculated with Eco-MLV vector
diluted with fresh medium in presence of cathepsin inhibitor III (200 mM). The transduction units obtained with DMSO-treated cells were set to 100%.
These experiments were repeated in triplicate, and results are shown as the mean +/2 SD. Asterisks indicate statistically significant differences
compared to the value from the DMSO-treated cells. (D) Cathepsin B (left panel) and L (right panel) activities of TE671 cell conditioned medium in
absence or presence of cathepsin inhibitor III were measured. Fluorescence intensities were indicated. This experiment was repeated three times, and
results are shown as means +/2 SD.
doi:10.1371/journal.pone.0026180.g003
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Eco-MLV infection of XC cells in the presence of cathepsin
inhibitor III occurs through acidic endosomes, ConA-pretreated
XC cells were inoculated with the Eco-MLV vector in the
presence of cathepsin inhibitor III. However, the treatment of XC
cells did not attenuate the Eco-MLV infection (Fig. 3C), showing
that the Eco-MLV infection of XC cells in the presence of
cathepsin inhibitor III does not require endosome acidification.
Taken together, these results indicate that the assumption is not
correct, and suggest that secreted cathepsins are not involved in
the XC cell-specific, pH-independent Eco-MLV infection.
Ampho-, Poly-, Xeno-, and XMRV-MLV vector infections
occur through acidic endosomes and require cathepsin
proteases in TE671 cells
It has already been reported that endosome acidification
inhibitors attenuate the Eco- and Ampho-MLV infections,
suggesting that these infections occur through acidic endosomes
[11,12]. To assess whether the Poly-, Xeno-, and XMRV-MLV
vector infections occur through acidic endosomes, the effects of
endosome acidification inhibitors, ConA and BFLA-1, on these
MLV vector infections were analyzed. Human TE671 cells were
pretreated with these inhibitors for 5 h, and were inoculated with
the MLV vectors in absence of the inhibitors. All of these MLV
vector infections were efficiently attenuated by the ConA (Fig. 4A)
or BFLA-1 treatment (Fig. 4B). The BFLA-1 treatment of TE671
cells expressing human CD4 did not affect infection by an HIV-1
vector carrying the Env protein of the CXCR4-tropic HXB2
HIV-1 strain. The ConA treatment enhanced the transduction
efficiency of this virus as previously reported [20,21], suggesting
that the HIV-1 vector infection do not require endosome
acidification, and attenuation of the MLV infections by the
inhibitors is not due to their suppressing effect on cell viability.
These findings indicate that the Ampho-, Poly-, Xeno-, and
XMRV-MLV vector infections all require endosome acidification
in human TE671 cells.
The Eco-MLV infection requires endosomal cathepsin prote-
ase B or L [13,14]. To assess whether the Ampho-, Poly-, Xeno-,
and XMRV-MLV vector infections also require cathepsin
proteases, the effect of CA-074Me on these MLV vector
infections were analyzed. CA-074Me is membrane permeable
and inhibits both cathepsins B and L [14,22]. TE671 cells were
pretreated with CA-074Me for 5 h, and were inoculated with the
MLV vectors diluted with fresh medium. The MLV vector
infections were efficiently attenuated by CA-074Me in a dose-
dependent manner, but the VSV-G-MLV vector infection was
not significantly inhibited (Fig. 4C). Biochemical study also
revealed that the CA-074Me treatment indeed attenuated cellular
cathepsin B activity in TE671 cells (Fig. 4D). These results
indicate that the Eco-, Ampho-, Poly-, Xeno-, and XMRV-MLV
vector infections of TE671 cells occur through acidic endosomes
and require cathepsin proteases.
pH-independent MLV infection in XC cells requires
endosomal cathepsin proteases
The Eco-MLV infection of XC cells does not require endosome
acidification. To assess whether the Ampho-, Poly-, Xeno-, and
XMRV-MLV vector infections of XC cells also lack this
requirement, the effect of ConA on these MLV vector infections
was analyzed. While ConA treatment did not inhibit these MLV
infections in XC cells (Fig. 4E), it did inhibit the VSV-MLV
infection, indicating that the ConA treatment suppressed endo-
some acidification. These results indicate that the Eco-, Ampho-,
Poly-, Xeno-, and XMRV-MLV vector infections of XC cells are
all independent of endosome acidification.
If the MLV infections of XC cells do not occur through acidic
endosomes, it may not require cathepsin proteases, because
secreted cathepsins are not involved in the pH-independent
infection of XC cells and these proteases primarily exist in acidic
endosomes. However, CA-074Me treatment inhibited the Eco-
MLV infection in XC cells as well as in NIH3T3 cells [14]. The
Ampho-, Poly, Xeno-, and XMRV-MLV infections in XC cells
were also suppressed by CA-074Me (Fig. 4F). CA-074Me
treatment indeed decreased cathepsin B activity in XC cells to
that in untreated NIH3T3 cells in which cathepsin B activity is
negative or extremely low [14] (Figs. 4D and G). These results
suggest that the MLV infections in XC cells are pH-independent
but require endosomal cathepsin proteases.
Cathepsin proteases are activated in the absence of
endosome acidification in XC cells
Because cathepsin proteases are activated by low pH in acidic
endosomes [23], endosome acidification inhibitors may inhibit
MLV infections by suppressing cathepsin protease activation. To
address this hypothesis, the effect of ConA treatment on activities
of cathepsins B and L in living cells were measured. ConA
treatment attenuated cathepsin B (Fig. 5A) and L (Fig. 5B)
activities in TE671 cells (P,0.05), but did not in XC cells,
suggesting that cathepsin proteases are activated without endo-
some acidification in XC cells.
Cathepsin B and L proteases are maturated by their processing
in acidic condition. To assess whether the acidification inhibitor
affects the cathepsin protease processing, Western immunoblotting
of cell lysates prepared from ConA-or DMSO-treated cells was
performed using an anti-mouse cathepsin L antibody. In mouse
NIH3T3 and rat L6 cells in which the Eco-MLV infection is pH-
dependent (Fig. 1B), levels of the cathepsin L precursor and
processed single chain proteins were elevated and reduced by the
ConA treatment, respectively, indicating that the ConA treatment
suppresses the cathepsin L processing. In contrast, levels of the
cathepsin L precursor and processed proteins (single and double
chains) were not affected by the ConA treatment in XC cells,
suggesting that ConA treatment does not attenuate cathepsin L
activity in XC cells. Interestingly, the cathepsin L processing
occurs less efficiently in XC cells than in NIH3T3 and L6 cells,
although the cathepsin L activity in XC cells was similar to that in
NIH3T3 cells (Fig. 4G). Cathepsin L cDNA was isolated from XC
cells by RT-PCR (Accession No. AB630323). The XC cell
cathepsin L has no change in amino acid sequence compared to
already reported rat cathepsin L sequences. Cathepsin B protein
was not detected in XC cells by Western immunoblotting,
probably because cathepsin B activity was relatively lower in XC
cells (Fig. 4G). Finally, these results indicate that cathepsins B and
L are activated without endosome acidification in XC cells.
MLV infections require dynamin-mediated endocytosis in
NIH3T3, XC, and TE671 cells
The above findings prompted us to speculate that these MLV
infections in XC cells occur through endosomes but do not require
endosome acidification, because cathepsin proteases are activated
independently of endosome acidification. To address this hypoth-
esis, the effect of an endocytosis inhibitor, dynasore, on the MLV
infections was analyzed. Dynasore is an inhibitor of dynamin
GTPase required for endocytosis [24]. Target cells were pretreated
with dynasore for 5 h and were inoculated with the Eco-MLV
vector diluted with fresh medium. The dynasore treatment
pH-Independent Infection by MLV in XC Cells
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cells (Fig. 6A). The inhibitory effect of dynasore on cell viability
(Fig. 6B) was much more modest than the inhibition of the Eco-
MLV infection. The dynasore treatment also inhibited the
Ampho-, Poly-, Xeno-, and XMRV-MLV infections in TE671
(Fig. 6C) and XC cells (Fig. 6D). However, dynasore treatment of
CD4-expressing TE671 cells did not inhibit infection by the HIV-
1 vector containing the HXB2 Env protein, consistent with
previous reports [20,21,25,26]. The VSV-G-mediated infection
was moderately inhibited by dynasore in XC and NIH3T3 cells,
but was not affected in TE671 cells (Fig. 6C). These results suggest
that the Eco-, Ampho-, Poly-, Xeno-, and XMRV-MLV infections
in XC cells require the dynamin-dependent endocytosis.
When NIH3T3 cells were inoculated with the Eco-MLV vector
diluted with the TE671 cell conditioned or cathepsin B-containing
medium, the inhibitory effect of ConA on the Eco-MLV infection
was minimized (Figs. 2A and 3A), suggesting that the Eco-MLV
infection in the presence of secreted cathepsin proteases occurs at
the plasma membrane. To assess this hypothesis, the effect of
dynasore on infection by the Eco-MLV vector diluted with the
TE671 cell conditioned or cathepsin B-containing medium was
analyzed. As expected, the infection was not significantly
suppressed by dynasore (P,0.05) (Fig. 6A). This result supports
that the Eco-MLV vector infection in the presence of secreted
cathepsin proteases occurs at the plasma membrane.
To confirm that the MLV infections occur through endosomes
even in XC cells, we analyzed the effects of siRNAs against
dynamin 2 mRNA on these MLV infections. Because mouse
NIH3T3, human TE671, and rat XC cells were used in this study,
we constructed siRNAs against mouse, human, and rat dynamin 2
mRNAs. As expected, the knockdown of dynamin 2 expression
mediated by the siRNAs suppressed the MLV vector infections in
mouse NIH3T3 (Fig. 7A), human TE671 (Fig. 7B), and rat XC
cells (Fig. 7C), but not the CXCR4-tropic HIV-1 and VSV
infections. The siRNAs indeed attenuated dynamin 2 expression
analyzed by Western immunoblotting (Fig. 7D). These results
indicate that the Eco-, Ampho-, Poly-, Xeno-, and XMRV-MLV
vector infections require dynamin 2-mediated endocytosis even in
XC cells.
Ebola virus infection is pH-independent in XC cells
Ebola virus infection also requires endosome acidification and
endosomal cathepsin proteases like the MLV infections [27].
Infection of XC cells by Ebola virus GP-pseudotyped MLV vector
might be low pH-independent. To assess this hypothesis, the effect
of ConA treatment on the Ebola-MLV vector infection was
analyzed. As expected, the ConA treatment inhibited the Ebola
virus GP-mediated infection in TE671 cells, but not in XC cells
(Fig. 8A). The Ebola virus GP-mediated infection was suppressed
by CA-074Me treatment in TE671 and XC cells (Fig. 8B),
indicating that the Ebola-MLV vector infection in XC cells
requires endosomal cathepsins but not endosome acidification.
However, dynasore treatment did not significantly attenuated the
Ebola-MLV infection in TE671 and XC cells (Fig. 8C), consistent
with the previous report showing that the Ebola virus infection
occurs through dynamin-independent macropinocytosis [28].
These results indicate that not only the MLV infections but also
the Ebola virus infection are pH-independent in XC cells.
ConA, CA-074Me, dynasore, siRNAs do not inhibit MLV
vector binding to target cells
To test whether MLV vector binding was modulated by ConA,
CA-074Me, or dynasore inhibitor, we monitored the vector-cell
complex formation in the presence of each inhibitor. The
antiserum used for this assay recognizes Env proteins of Eco-,
Ampho-, Poly, and Xeno-MLVs in Western immunoblotting [29].
The Eco-MLV vector bound to TE671/mCAT1 cells but not to
TE671 cells (Fig. 9A), indicating that the binding is mCAT1-
dependent, as previously reported in human NP2 cells [30].
Binding of the Eco-MLV vector to target cells was not suppressed
by the inhibitors in XC (Fig. 9B), NIH3T3, and TE671 (data not
shown) cells. Similarly, the siRNA-mediated knockdown of
dynamin 2 expression did not inhibit the formation of MLV/
target cell complexes (data not shown). Thus, the inhibitors and
the siRNA-mediated dynamin 2 knockdown did not attenuate the
MLV vector infections by suppressing MLV particle binding to the
target cells.
Digestion of MLV Env proteins by cathepsin B
This study indicates that cathepsin proteases are required for
the Eco-, Ampho-, Poly-, Xeno-, and XMRV-MLV vector
infections. It has been reported that the Eco-MLV Env protein
is digested by cathepsin B [13], suggesting that the digestion of the
Env protein activates the entry capability. To assess whether the
Ampho-, Poly-, Xeno-, and XMRV Env proteins are digested by
cathepsin B, purified MLV vector particles were treated with
cathepsin B (100 ng/ml) at pH 5.0, and analyzed by Western
immunoblotting. Digested products were detected in the Eco-,
Ampho-, and Poly-Env proteins (Fig. 10). It has been reported that
52 and 28 kDa digested products were detected in digestion of the
Eco-Env protein by cathepsin B, and the 28 kDa peptide contains
N-terminal receptor-binding domain [13]. In our study, the
52 kDa product was detected, but the 28 kDa was not. Because
the anti-MLV SU antiserum used in our study recognized all of
the Eco-, Ampho-, Poly-, Xeno-, and XMRV-Env proteins, the
antiserum primarily recognizes the conserved C-terminal domains
of these Env proteins, but not the variable N-terminal receptor
binding domains. Therefore, the 28 kDa product was not detected
by this antiserum. Digested products were not detected in the
Xeno- and XMRV-Env proteins. However, amounts of the
undigested SU proteins were reduced by the cathepsin B
treatment. This result suggests that the Xeno- and XMRV-Env
proteins are digested by cathepsin B at many cleavage sites.
Figure 4. Ampho-, Poly-, Xeno-, and XMRV-MLV vector infections require endosome acidification and cathepsin proteases. (A)
TE671, TE671/mCAT1, or TE671/CD4 cells were pretreated with ConA for 5 h and were inoculated with the Eco-, Ampho-, Poly-, Xeno-, XMRV-MLV, or
HXB2-HIV-1 vector. (B) TE671 or TE671/CD4 cells were pretreated with BFLA-1, and were inoculated with the Ampho-, Poly-, Xeno-, VSV-, XMRV-, VSV-
MLV, or HXB2-HIV-1 vector. (C) TE671 or TE671/mCAT1 cells were pretreated with CA-074Me and were inoculated with the Eco-, Ampho-, Poly-, Xeno-,
VSV-, or XMRV-MLV vector. The transduction units obtained with DMSO-treated cells were set to 100%. These experiments were repeated in triplicate,
and results are shown as the mean +/2 SD. Asterisks indicate statistically significant differences compared to the value from the DMSO-treated cells.
(D) Cathepsin B activity of cells lysates from CA-074Me-treated cells was measured. Fluorescence intensities are shown. XC cells were treated with
ConA (panel E) or CA-074Me (panel F), and were inoculated with the Eco-, Ampho-, Poly-, Xeno-, XMRV-, or VSV-MLV vector. These experiments were
repeated in triplicate, and results are shown as the mean +/2 SD. Asterisks indicate statistically significant differences compared to the value from the
DMSO-treated cells. (G) Activities of cathepsins B (left panel) and L (right panel) were measured in cell lysates from XC, NIH3T3, 293T, and TE671 cells.
Fluorescence intensities were indicated. These experiments were repeated three times, and results are shown as the mean +/2 SD.
doi:10.1371/journal.pone.0026180.g004
pH-Independent Infection by MLV in XC Cells
PLoS ONE | www.plosone.org 8 October 2011 | Volume 6 | Issue 10 | e26180Discussion
The XC cell-specific, pH-independent MLV infection is one of
the well-recognized mysteries in the MLV study field, but the
mechanism had not been elucidated for long time. It had been
generally accepted that the Eco-MLV entry into XC cells occurs at
the plasma membrane, and not through endosomes [11].
However, the CA-074Me treatment attenuated MLV infections
in XC cells, showing that the MLV infections of XC cells require
endosomal cathepsin proteases. This conflicting result prompted
us to challenge the previous theory that the Eco-MLV infection in
XC cells occurs at the plasma membrane [11].
The propeptide of cathepsin proteases facilitates folding of the
enzymes, acts as an inhibitor preventing proteolytic activity of the
enzymes, and is responsible for targeting to endosomes [23]. The
propeptide of cathepsin protease masks its active site, and inhibits
the protease activity. Conformation of the propeptide-containing
cathepsin protease is changed in acidic condition of endosomes,
and the active site is exposed. After the active site is exposed by
low pH, the propeptide of cathepsin is cleaved by itself or other
Figure 5. Treatment with endosome acidification inhibitors does not alter activities of cathepsins B and L in XC cells. TE671 and XC
cells were treated with ConA (3 nM) or DMSO. The treated cells were stained with the cathepsin B (panel A) or L (panel B) detection reagent. Closed
areas indicate cells unstained with the reagents. Open areas indicate cells treated with DMSO and stained with the reagent. Grey areas indicate cells
treated with ConA and stained with the reagent. Means of fluorescent intensity obtained with DMSO-treated cells were set to 100%. These
experiments were repeated in triplicate, and results are shown as the mean +/2 SD. Asterisks indicate statistically significant differences compared to
the DMSO-treated cells. Mouse NIH3T3, rat L6, and XC cells were treated with DMSO or ConA (3 nM). Cell lysates from the treated cells were analyzed
by Western immunoblotting using an anti-mouse cathepsin L ancbody (panel C).
doi:10.1371/journal.pone.0026180.g005
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is thought that treatment by the endosome acidification inhibitors
prevent the MLV infections by suppressing the cathepsin protease
activation. The treatment did not inhibit cathepsin protease
activity and cathepsin L processing in XC cells, indicating that
cathepsin proteases are activated independently of endosome
acidification in XC cells. This independence may explain why the
MLV infections in XC cells do not require endosome acidification
and are not attenuated by the endosome acidification inhibitors.
Thus, the MLV infections in XC cells occur through endosomes
and the pH-independent activation of endosomal cathepsin
proteases induces the pH-independent MLV infections in XC
cells (Fig. 11). The dynasore treatment and siRNA-mediated
dynamin 2 knockdown inhibited the MLV infections in all
examined cells, strongly supporting the above observations. These
results indicate that the MLV particles are internalized by
endocytosis for a productive infection in XC cells similar to other
susceptible cells.
The MLV and Ebola virus Env proteins used in this study
recognize different infection receptors as described in Introduc-
tion. It is suggested that interactions with these different receptors
lead to the same endocytic entry pathway for all these viruses.
Based on this model of the virus entry pathway, the virus Env
proteins are activated by cathepsin-mediated digestion after
internalized into acidic endosomes. Therefore, it is unlikely that
viral proteins directly induce the internalization of viral particles
into endosomes. This suggests that these different infection
receptors are responsible for the endocytic entry pathway.
Figure 6. MLV infections are inhibited by dynasore. (A) XC and NIH3T3 cells were pretreated with dynasore and were inoculated with the Eco-
MLV vector diluted with fresh, TE671 cell conditioned, or cathepsin B (100 ng/ml)-containing medium. (B) XC and NIH3T3 cells were treated with
dynasore, washed, and cultured for 48 h. Cells resistant to trypan blue staining were quantified. (C) TE671, TE671/mCAT1, or TE671/CD4 cells were
pretreated with dynasore and were inoculated with the Eco-, Ampho-, Poly-, Xeno-, XMRV-, VSV-MLV, or HXB2-HIV-1 vector. (D) XC cells were
pretreated with dynasore and were inoculated with the Ampho-, Poly-, Xeno-, XMRV-, or VSV-MLV vector. The transduction units obtained with
DMSO-treated cells were set to 100%. These experiments were repeated in triplicate, and results are shown as the mean +/2 SD. Asterisks indicate
statistically significant differences compared to the value from the DMSO-treated cells.
doi:10.1371/journal.pone.0026180.g006
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contained cathepsin protease activity, and induced the pH-
independent MLV vector infection in NIH3T3 cells. Because
the MLV vector-producing TELCeB6 cells were constructed from
TE617 cells [31], their cells secrete cathepsin proteases as well as
the MLV vector particles. Env proteins on the MLV vector
particles should be digested by secreted cathepsin proteases, soon
after the vector particles are released from the vector-producing
cells. However, infection by the MLV vectors produced from
TELCeB6 cells required endosome acidification and cathepsin
proteases in NIH3T3 cells. Dilution of the MLV vector with the
conditioned or cathepsin B-containing medium significantly
attenuated the transduction efficiency, suggesting that the digested
Env proteins are unstable or released from the MLV vector
particles. Indeed, the digested products of Env proteins were not
detected in the MLV vector preparations. Therefore, infections by
the MLV vectors produced from transfected TELCeB6 cells
require endosome acidification and cathepsin proteases in
NIH3T3 cells.
Cathepsin L activity in XC cells was similar to that in NIH3T3
cells, and cathepsin L processing occurred less efficiently in XC
cells than in NIH3T3 and L6 cells, suggesting that unprocessed
cathepsin L is active in XC cells. It has been reported that
glycosaminoglycans such as chondroitin sulfate and heparin
facilitate cathepsin B activation at natural pH [23]. However,
treatment of XC cells with chondroitinase or heparinase did not
affect the pH-independent Eco-MLV vector infection (data not
shown). Mechanism by which cathepsin proteases are activated
without endosome acidification in XC cells is unknown. It has
been reported that disruption of microtubules markedly reduces
the Eco-MLV infection in NIH3T3 cells, but does not in XC cells
[19]. Based on the previous theory that the Eco-MLV infection
occurs at cell surface in XC cells but does through endosomes in
NIH3T3 cells, the authors have explained that the difference is
resulted from the different entry pathways. However, since it was
found that the Eco-MLV infection occurs through endosomes in
XC and NIH3T3 cells, endosomes in which cathepsin proteases
are activated without acidification might be different from those in
which cathepsins are activated by acidification. Microtubule-
independent endocytosis might induce endosomes in which
cathepsins are activated without acidification, and specifically
occur in XC cells.
Figure 7. MLV infections are inhibited by siRNA-mediated knockdown of dynamin 2 expression. (A) NIH3T3 cells were transfected with
an siRNA against mouse dynamin 2 mRNA, and were inoculated with the Eco-MLV vector. (B) TE671 or TE671/CD4 cells were transfected with an
siRNA against human dynamin 2 mRNA, and were inoculated with the Ampho-, Poly-, Xeno-, XMRV-, VSV-MLV, or HXB2-HIV-1 vector. (C) XC cells were
transfected with an siRNA against rat dynamin 2 mRNA, and were inoculated with the Eco-, Ampho-, Poly-, Xeno-, XMRV- or VSV-MLV vector. The
transduction units obtained with DMSO-treated cells were set to 100%. These experiments were repeated in triplicate, and results are shown as the
mean +/2 SD. Asterisks indicate statistically significant differences compared to the value from the DMSO-treated cells. (D) Dynamin 2 protein
expression in the siRNA-transfected cells was analyzed by Western immunoblotting using an anti-dynamin 2 antibody. Actin expression was analyzed
as control.
doi:10.1371/journal.pone.0026180.g007
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attenuated the MLV, vector infections, but moderately (1/2)
suppressed cathepsin activities. MLV vectors were diluted to
induce about 20 to 40 infected cells in 1 mm
2. Because 6-cm
dishes were used in this experiment, it was estimated that about
10
5 cells are infected in a dish. In the inhibitor-treated cells, 10
4
cells were still infected. Therefore, it is not suspicious that
cathepsin activity of the target cells correlates to susceptibility to
the MLV infections.
The membrane-permeable CA-074Me treatment inhibited the
MLV infections at 40 mM, but the unpermeable cathepsin
inhibitor III did not even at 200 mM. We have previously reported
that an unpermeable cathepsin L inhibitor, CLIK148, suppresses
the Eco-MLV infection at 1000 mM [14]. All these inhibitors can
be incorporated into endosomes by endocytosis. Additionally, the
membrane-permeable inhibitor can reach endosomes by passing
through membranes. Therefore, the membrane-permeable inhib-
itor suppressed the MLV vector infections at lower concentration
than the unpermeable inhibitors.
In this study, the VSV-G-pseudotyped MLV vector infection
was moderately suppressed by dynasore in XC and NIH3T3 cells,
and was not in TE671 cells. The knockdown of dynamin 2
expression by siRNAs did not affect the VSV-G-pseudotyped
vector infection. Although the VSV-G-mediated infection also
occurs through endosomes, it has been reported that VSV
infection enters host cells through endosomes incompletely coated
with clathrin [32]. The unconventional endocytosis might not
require dynamin 2, and the VSV-G-mediated infection might be
independent of dynamin 2.
Because the Eco-MLV infection is pH-independent and
induced pH-independent syncytium formation in XC cells, it
had been widely accepted that the Eco-MLV infection in XC cells
occurs at cell surface [11]. It had been thought that the pH-
independent Eco-MLV infection always links to the pH-indepen-
dent syncytium formation by the Eco-MLV infection. However,
Wilson et al have found a transformed cell line, NIH3T3/DTras,
in which the Eco-MLV infection is pH-dependent but induces the
pH-independent syncytium formation [33], suggesting that the
membrane fusion mechanisms for the viral entry and for
syncytium formation are different, consistent with our previous
finding [8].
It had been generally accepted that the Eco-MLV entry into
XC cells occurs at the plasma membrane, and not through
endosomes [11]. We believe that our study resolved the
mechanism by which the MLV infections are pH-independent
in XC cells at last. The conclusion made in this study does not
support the previous conclusion and represent the novel finding.
Materials and Methods
Cells
Human 293T [34], NP2 [35], and TE671 [31], mouse NIH3T3
[36] and SC-1 [37], rat XC [18] and L6 [38], and monkey COS7
[39] cells were cultured in Dulbecco’s modified Eagle’s medium
(Wako) supplemented with 8% fetal bovine serum (Biosources) at
37uCi n5 %C O 2. MLV vector producing cells were constructed
by stable transfection of TELCeB6 cells [31] with ecotropic Friend
[8], amphotropic [40], polytropic [41], xenotropic [6], or XMRV
[42] Env expression plasmid as previously reported [29]. Eco-
MLV receptor-expressing 293T and TE671 cells were constructed
using an mCAT1-encoding MLV vector as previously described
[17].
Retrovirus vectors
Culture supernatants of TELCeB6 cells [31] stably transfected
with the ecotropic, amphotropic, polytropic, xenotropic, or
XMRV Env protein expression plasmid were used to inoculate
target cells. The VSV-G- or Ebola virus GP-pseudotyped MLV
vector was constructed by transient transfection of TELCeB6 cells
with a VSV-G [43] or Ebola virus GP expression plasmid [28].
The HIV-1 vector containing the HXB2 Env protein was
constructed by transient transfection of COS7 cells with the
Figure 8. Ebola virus infection in XC cells is pH-independent. TE671 and XC cells were pretreated with ConA (panel A), CA-074Me (panel B), or
dynasore (panel C), and were inoculated with the Ebola virus GP- or VSV-G-pseudotyped MLV vector. The transduction units obtained with DMSO-
treated cells were set to 100%. These experiments were repeated in triplicate, and results are shown as the mean +/2 SD. Asterisks indicate
statistically significant differences compared to the value from the DMSO-treated cells.
doi:10.1371/journal.pone.0026180.g008
pH-Independent Infection by MLV in XC Cells
PLoS ONE | www.plosone.org 12 October 2011 | Volume 6 | Issue 10 | e26180pH-Independent Infection by MLV in XC Cells
PLoS ONE | www.plosone.org 13 October 2011 | Volume 6 | Issue 10 | e26180packaging construct of HIV-1 [44], the LacZ-encoding HIV-1
vector genome [45], and the HXB2 Env expression plasmids as
previously reported [46]. The culture media from transfected cells
was replaced with fresh media 24 h after transfection, and the cells
were cultured for an additional 24 h. Supernatants of transfected
cell cultures were used to inoculate target cells.
Transduction assay
Target cells were plated onto 6-cm dishes, and cultured for
24 h. The cells were pretreated with ConA (Sigma), BFLA-1
(Sigma), CA-074Me (Sigma), or dynasore (Calbiochem) for 5 h.
The treated cells were washed with media to remove the
inhibitors. Culture supernatants of the vector-producing cells were
diluted with fresh or conditioned media as follows: the Eco- and
Ampho-MLV vectors were diluted 1000-fold and the Poly-, Xeno-
and VSV-MLV as well as XMRV vectors were diluted 10-fold.
The Ebola virus GP-pseudotyped MLV vector was not diluted.
Target cells were inoculated by complete replacement of culture
medium by diluted viral vectors. By the dilution, 20–40 infected
cells were detected in 1 mm
2 of control DMSO-treated cells.
Alternatively, the target cells were inoculated with the MLV
vectors in presence of cathepsin inhibitor III (Calbiochem) or
purified cathepsin B (Calbiochem). The inoculated cells were
cultured for 48 h, and then stained with 5-bromo-4-chloro-3-
indolyl-b-D-galactopyranoside (Wako). The blue cells were
counted in 10 randomly selected microscopic fields, and relative
values to the infected cell numbers in control cells were compared
between samples.
Cell viability
Target cells were treated with the inhibitors for 5 h and were
washed with media to remove the inhibitors. Fresh media was
added to the cells and they were cultured for 48 h. The cells were
then collected and stained with trypan blue (Cosmo Bio). The
amount of unstained cells was quantitated in a counting chamber.
Cathepsin protease activity assay
To measure the activities of cathepsins B and L in cell lysates,
the cathepsin B and L activity assay kits (BioVision, Mountain
View, CA) were used, respectively. The cathepsin activity assay kit
is a fluorescence-based assay that utilizes the preferred cathepsin B
or L substrate amino acid sequence labeled with amino-4-
trifluoromethyl coumarin (AFC). Cell lysates that contain
cathepsin B or L will cleave the synthetic AFC-labeled substrate
to release free AFC, and generate fluorescence. Cell lysates
prepared from 1610
6 cells were incubated with the cathepsin B or
L substrate for 1 h at 37uC, and fluorescence intensity at 505 nm
was measured by a fluorescence microplate reader (PerkinElmer).
Cathepsin activities in living cells were measured as follows.
Cells were stained with the cathepsin B or L detection reagent
(Cell Technology, Minneapolis, MN). The reagent utilizes
fluorophore cresyl violet that is bi-substituted by an amide linkage
to a peptide that contains a cathepsin B or L target cleavage
sequence. In this form, the cresyl violet leaving group is non-
fluorescent. Following cleavage at the amide linkage site by
cathepsin B or L in living cells, the mono and non-substituted
cresyl violet fluorophores generate red fluorescence. The stained
Figure 9. Binding of the MLV vectors to target cells is not affected by ConA, CA-074Me, or dynasore treatments. (A) Binding of the
Eco-MLV vector particles to TE671 (upper panel) and TE671/mCAT1 (lower panel) was analyzed. (B) XC cells were pretreated with DMSO, ConA, CA-
074Me, or dynasore, and were incubated with the Eco-, Ampho-, Poly-, or Xeno-MLV vector. The fluorescence intensities obtained with DMSO-treated
cells were set to 100%. These experiments were repeated in triplicate, and values are shown as the mean +/2 SD.
doi:10.1371/journal.pone.0026180.g009
Figure 10. Digestion of MLV Env proteins by cathepsin B. The MLV vector particles were treated with cathepsin B (100 ng/ml). The products
were analyzed by Western immunoblotting using the anti-MLV SU antiserum.
doi:10.1371/journal.pone.0026180.g010
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CA) to measure fluorescence intensity of the cells.
siRNA-mediated knockdown of dynamin expression
Nucleotide sequences of sense strands of siRNAs against human,
rat, and mouse dymanin 2 mRNAs are CCC UAC GUA GCA
AAC UAC AGA, GAC UGC UGA GUC GUU GUC UUG, and
GCA CCC ACA GUG UAG GAC AGU, respectively. A siRNA
against green fluorescence protein (GFP) was used as a control.
The nucleotide sequence of sense strand of the GFP siRNA was
CUG GAG UUG UCC CAA UUC UUG. These siRNAs were
designed and synthesized by RNAi Co. LTD. Cells were
transfected with siRNAs (400 pmol) by TransIT TKO (12 ml)
(Mirus).
Western immunoblotting
Cell lysates were subjected to sodium dodecyl sulfate polyacryl-
amide gel electrophoresis (BioRad), and were transferred onto a
PVDF membrane (Millipore). The membrane was treated with an
anti-dynamin 2, -cathepsin L (Santa Cruz), -MLV SU, or -p30
antiserum [29], and then with a horseradish peroxidase-conjugat-
ed protein G (BioRad). The anti-MLV SU antiserum was obtained
from ViroMed Biosafety Laboratories. Proteins G-bound poly-
peptides were visualized by ECL Western blotting detection
reagents (Amersham Pharmacia Biotech).
MLV vector binding assay
The MLV vector binding assay was performed as reported
previously [30,47]. Target cells (1610
6) were incubated with the
MLV vector solution for 1 h at 4uC, and unbound vector particles
were removed by two washes with PBS. Vector-cell complexes
were incubated sequentially at 4uC with the goat anti-MLV SU
antiserum and then with PE-conjugated anti-goat IgG antibody
(Jackson Laboratories). Fluorescence intensity of the cells was
analyzed by a flow cytometer (BD Bioscences).
Digestion of MLV Env proteins by cathepsin B
Culture supernatants of the MLV vector producing cells were
filtered through 0.45 mm membranes (MILLIPORE), and centri-
fuged through 20% sucrose to collect MLV particles. The MLV
particles were incubated with bovine cathepsin B (Calbiochem) at
37uC, and subjested to SDS-PAGE. MLV proteins were analyzed
by Western immunoblotting using the anti-MLV SU or -p30
antiserum.
Statistical analysis
Differences between two groups of data were determined by the
Student’s t-test. The statistical significance was set at p,0.05 for
all tests.
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